Prime Medicine, known for its goal of treating hundreds of diseases with CRISPR, says it's narrowing its focus to two. It ...

Shares of biotechnology company Prime Medicine, Inc. (PRME) fell 18% on Monday afternoon after the company announced a ...

The London Biotechnology Show returns for its highly anticipated second edition, building on the remarkable success of its ...

A Massachusetts-based wound care and sports medicine company announced plans for its brand-new biomanufacturing facility ...

Smithfield lease Mass. biotech offered millions to manufacture skin in R.I. Boston biotech aims to put some skin in the RI ...

The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving ...

Prime Medicine is eliminating 25% of its workforce in a restructuring that includes the company pivoting its prime ...

Durham-based Atsena Therapeutics has received Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration (FDA) for ATSN-201, its gene therapy product for the ...

The Biotechnology Program has also expanded its STEM outreach efforts to include a summer internship program for high school ...

Healthcare Patent Filing Outsourcing Market, revealing compelling growth prospects over the next decade. According to the ...

Stylus Medicine is unsheathing, penning a mission to develop next-gen in vivo genetic medicines with $85 million in hand, ...

Shortly afterward, up-and-coming venture capitalist Robert Swanson pitched Boyer on co-founding the first biotech company, which they named Genentech, Inc. Boyer and Cohen had produced a new era of ...